Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

NCT01246908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Placebo
DRUG: CX157 (TriRima)

Sponsor

CeNeRx BioPharma Inc.